Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
cosimo.durante@uniroma1.it
Cosimo Durante
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
cosimo.durante@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Drawing as a way of knowing: How a mapping model assists preoperative evaluation of patients with thyroid carcinoma
JOURNAL OF CLINICAL MEDICINE
2024
Head-to-head comparison of American, European, and Asian TIRADSs in thyroid nodule assessment: systematic review and meta-analysis
EUROPEAN THYROID JOURNAL
2024
Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
2024
Effects of lenvatinib on glucose, cholesterol, triglycerides and estimated cardiovascular risk in patients with advanced thyroid cancer
ENDOCRINE
2024
Thyroid nodules: diagnosis and management
NATURE REVIEWS. ENDOCRINOLOGY
2024
Multiparametric ultrasound evaluation of thyroid nodules
ULTRASCHALL IN DER MEDIZIN
2024
Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2024
Validation of ACR TI-RADS performance in transition age: results from a multicenter retrospective study by the TALENT study group
ENDOCRINE
2024
A reappraisal of suspicious sonographic features of thyroid nodules: shape is not an independent predictor of malignancy
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
2023
The role of miR-139-5p in radioiodine-resistant thyroid cancer
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2023
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance
BIOMÉDECINE & PHARMACOTHÉRAPIE
2023
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
2023
Ultrasound screening for thyroid nodules and cancer in individuals with family history of thyroid cancer: a micro-costing approach
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2023
Laterocervical lymph node metastases from suspected thyroidal primary site that turned out to be metastases of lung cancer: A case report
CLINICAL CASE REPORTS
2023
A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis
THYROID
2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value
BIOMARKER RESEARCH
2023
Randomized-comparison study on dissection of the central compartment of the neck and no surgical dissection in patients with initial thyroid cancer, negative pre-operative neck lymph-node diagnosis and intermediate–high molecular risk
Atti Convegno - V Congresso SIUEC 2023
2023
The Size of a Thyroid Nodule with ACR TI-RADS Does Not Provide a Better Prediction of the Nature of the Nodule: A Single-Center Retrospective Real-Life Observational Study
HEALTHCARE
2023
International Expert Consensus on US Lexicon for Thyroid Nodules
RADIOLOGY
2023
1
2
3
4
5
6
7
8
seguente ›
ultima »
Progetti di Ricerca
Use of a triple-component molecular assay in thyroid nodule aspirates to improve diagnostic accuracy of cytology and personalize management of thyroid cancer patients
Predictive molecular signature associated with radioiodine-resistance in thyroid cancer:in vivo and in vitro studies
Machine learning approach to predict thyroid cancer recurrence in the Italian Thyroid Cancer Observatory (ITCO) database
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma